FATE THERAPEUTICS INC shareholders Q3 2023

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.

FATE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TUDOR INVESTMENT CORP ET AL 50,187$106,3960.00%
Verition Fund Management LLC 52,654$111,6260.00%
Simplicity Solutions, LLC 12,012$25,4650.00%
Vanguard Personalized Indexing Management, LLC 14,354$30,4300.00%
FMR LLC 307,630$652,1750.00%
Asset Dedication, LLC 55$00.00%
DIMENSIONAL FUND ADVISORS LP 715,149$1,516,2370.00%
US BANCORP \DE\ 2,405$5,0990.00%
VOYA INVESTMENT MANAGEMENT LLC 81,821$173,4610.00%
FRANKLIN RESOURCES INC 16,546$35,0770.00%
Daiwa Securities Group Inc. 360$10.00%
BANK OF AMERICA CORP /DE/ 192,072$407,1920.00%
PNC FINANCIAL SERVICES GROUP, INC. 916$1,9420.00%
STIFEL FINANCIAL CORP 64,129$135,9530.00%
Eagle Bay Advisors LLC 76$1610.00%
METROPOLITAN LIFE INSURANCE CO/NY 4,525$9,5930.00%
SIMPLEX TRADING, LLC 319$00.00%
WELLS FARGO & COMPANY/MN 34,305$72,7260.00%
Brevan Howard Capital Management LP 17,337$36,7540.00%
AMERICAN CENTURY COMPANIES INC 37,062$78,5710.00%
External links

This page lists FATE THERAPEUTICS INC's shareholders in Q3 2023. To view FATE THERAPEUTICS INC's shareholder history, click here.